Ashish Tripathi is the founder and CEO of Tzar Labs and a Promoter Director of Epigeneres Biotech. The company has made a series of major breakthroughs in molecular diagnostics and he is spearheading the global launch. Prior to this, Ashish was the National TMT Head of Edelwiess IB and has had 20+ years of investment banking /corporate finance, M&A and corporate strategy experience across Australia, Europe, North America, Asia and Middle East. He has worked for a variety of MNCs, including Edelweiss, Ernst & Young, Avendus, Fairfax, Mincom, NTT Communications, Deutsche Bank and Deloitte Touché Tohmatsu. Ashish has also completed his MBA from Melbourne Business School, Australia.